PHC (PARIS HEPATOLOGY CONFERENCE) 2021 – PROGRAM- MONDAY

Program of the day

MONDAY March 8th

  • The COVID-19, NASH and other liver diseases: lessons learned - Thomas BERG (Germany)
  • The impact of COVID-19 on the HCV elimination program - Antonio CRAXI (Italy)
  • DISCUSSION
  • Is elimination of HBV realistic ? - Seng Gee LIM (Singapore)
  • NUC therapy: the role of TAF - Maria BUTI (Spain)
  • DISCUSSION
  • 15:00- 15:10 BREAK & VISIT OF THE BOOTHS
  • DISCUSSION
  • 17:15 - 17:25 BREAK & VISIT OF THE BOOTHS
  • 18:30 - 19:30 ABBVIE SYMPOSIUM Live
  • Driving change in the ‘new normal’ - the importance of simplified and decentralized HCV care
  • The lasting impact of COVID-19 on HCV care and elimination efforts - Robert FLISIAK (Poland)
  • Simplified, decentralized care - how do DAAs make this feasible ? - Marc BOURLIERE (France)
  • Evolving your role as an HCV specialist: from concept to practice - Joaquin CABEZAS (Spain)